29 results on '"Sundstrom, Stein"'
Search Results
2. Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer
3. How Do Elderly Poor Prognosis Patients Tolerate Palliative Concurrent Chemoradiotherapy for Locally Advanced Non–Small-Cell Lung Cancer Stage III? A Subset Analysis From a Clinical Phase III Trial
4. Palliative External Beam Thoracic Radiation Therapy of Non-Small Cell Lung Cancer
5. Poor Prognosis Patients with Inoperable Locally Advanced NSCLC and Large Tumors Benefit from Palliative Chemoradiotherapy: A Subset Analysis from a Randomized Clinical Phase III Trial
6. A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer
7. Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy
8. A prospective phase II study: High-dose pemetrexed as second-line chemotherapy in small-cell lung cancer
9. Pemetrexed Plus Cisplatin or Pemetrexed Plus Carboplatin for Chemonaïve Patients with Malignant Pleural Mesothelioma: Results of the International Expanded Access Program
10. Treatment outcome in performance status 2 advanced NSCLC patients administered platinum-based combination chemotherapy
11. Endoanal Ultrasound is of Little Value in Follow-Up of Anal Carcinomas
12. Palliative Thoracic Radiotherapy in Locally Advanced Non-small Cell Lung Cancer: Can Quality-Of-Life Assessments Help in Selection of Patients for Short- or Long-Course Radiotherapy?
13. Immediate or delayed radiotherapy in advanced non-small cell lung cancer (NSCLC)? Data from a prospective randomised study
14. Second-line chemotherapy in recurrent small cell lung cancer: Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen)
15. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up
16. Treatment of Malignant Pleural Mesothelioma with Carboplatin, Liposomized Doxorubicin, and Gemcitabine A Phase II Study
17. Surgery for NSCLC stages T1-3N2M0 having preoperative pathologically verified N2 involvement: A prospective randomized multinational phase III trial by the Nordic Thoracic Oncology Group.
18. P1-124: Malignant mesothelioma: prognosis not as bad as generally believed
19. C5-01: Open-label study of pemetrexed alone or in combination with a platinum in chemonaïve patients (pts) with malignant pleural mesothelioma (MPM): Results from the International Expanded Access Program (EAP)
20. PD4-2-4: Outcome of patients with WHO performance status 2 in a randomized trial comparing vinorelbine/carboplatin with gemcitabine/carboplatin in advanced NSCLC
21. Anal carcinoma in mid-Norway 1970–2000
22. PD4-3-8: Survival of patients with advanced non-small cell lung cancer before and after the general introduction of palliative chemotherapy in Norway - a population based study
23. A3-04: A phase III study by the Norwegian Lung Cancer Group: Pemetrexed + carboplatin vs. gemcitabine + carboplatin as first-line chemotherapy in stage IIIB/IV non-small cell lung cancer
24. O-122 Hypofractionated palliative thoracic radiotherapy (TRT) (17 Gy/2 fractions) in advanced non-small cell lung carcinoma (NSCLC) is equivalent to more protracted or higher dose TRT concerning symptom control and survival. Results from a phase III trial
25. O-87 Duration of chemotherapy and survival in advanced non-small cell lung cancer (NSCLC). A multicenter, prospective randomised study
26. O-57 Quality of life as related to duration of chemotherapy in advanced non-small cell lung cancer: A randomized study comprising 297 patients
27. Malignant mesothelioma: prognosis not as bad as generally believed.
28. Outcome of patients with WHO performance status 2 in a randomized trial comparing vinorelbine/carboplatin with gemcitabine/carboplatin in advanced NSCLC.
29. Open-label study of pemetrexed alone or in combination with a platinum in chemonaïve patients (pts) with malignant pleural mesothelioma (MPM): Results from the International Expanded Access Program (EAP).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.